Dr. Benjamin Paluch
Recent Articles
MA Biotech Reports Positive Meeting with FDA 09/09/2024
Replimune Group Inc.'s (REPL:NASDAQ) announced a successful pre-Biologics License Application (BLA) meeting with the FDA, according to a Roth MKM research note.
Due to permission requirements, not all quotes are shown.
